SEARCH

SEARCH BY CITATION

References

  • 1
    Larsson SC,Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007; 86: 55665.
  • 2
    Raju J,Bird RP. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. Cancer Res 2003; 63: 6595601.
  • 3
    Rapp K,Klenk J,Ulmer H,Concin H,Diem G,Oberaigner W,Schroeder J. Weight change and cancer risk in a cohort of more than 65,000 adults in Austria. Ann Oncol 2008; 19: 6418.
  • 4
    Bruce WR,Wolever TM,Giacca A. Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance. Nutr Cancer 2000; 37: 1926.
  • 5
    Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001; 131: 3109S20S.
  • 6
    Pisani P. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 2008; 114: 6370.
  • 7
    Tran TT,Medline A,Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 1996; 5: 101315.
  • 8
    Corpet DE,Jacquinet C,Peiffer G,Tache S. Insulin injections promote the growth of aberrant crypt foci in the colon of rats. Nutr Cancer 1997; 27: 31620.
  • 9
    Ma J,Giovannucci E,Pollak M,Leavitt A,Tao Y,Gaziano JM,Stampfer MJ. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 2004; 96: 54653.
  • 10
    Wei EK,Giovannucci E,Fuchs CS,Willett WC,Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005; 97: 168894.
  • 11
    Tamakoshi K,Toyoshima H,Wakai K,Kojima M,Suzuki K,Watanabe Y,Hayakawa N,Yatsuya H,Kondo T,Tokudome S,Hashimoto S,Suzuki S, et al. Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in Japan. Oncology 2005; 68: 45461.
  • 12
    Whitehead JP,Richards AA,Hickman IJ,Macdonald GA,Prins JB. Adiponectin—a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006; 8: 26480.
  • 13
    Schraw T,Wang ZV,Halberg N,Hawkins M,Scherer PE. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology 2008; 149: 227082.
  • 14
    Petridou ET,Mitsiades N,Gialamas S,Angelopoulos M,Skalkidou A,Dessypris N,Hsi A,Lazaris N,Polyzos A,Syrigos C,Brennan AM,Tseleni-Balafouta S, et al. Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies. Oncology 2007; 73: 2619.
  • 15
    Bluher M,Williams CJ,Kloting N,Hsi A,Ruschke K,Oberbach A,Fasshauer M,Berndt J,Schon MR,Wolk A,Stumvoll M,Mantzoros CS. Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training. Diabetes Care 2007; 30: 311015.
  • 16
    Yamauchi T,Kamon J,Ito Y,Tsuchida A,Yokomizo T,Kita S,Sugiyama T,Miyagishi M,Hara K,Tsunoda M,Murakami K,Ohteki T, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 7629.
  • 17
    Yatagai T,Nagasaka S,Taniguchi A,Fukushima M,Nakamura T,Kuroe A,Nakai Y,Ishibashi S. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003; 52: 12748.
  • 18
    Yang WS,Lee WJ,Funahashi T,Tanaka S,Matsuzawa Y,Chao CL,Chen CL,Tai TY,Chuang LM. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 381519.
  • 19
    Goldfine AB,Kahn CR. Adiponectin: linking the fat cell to insulin sensitivity. Lancet 2003; 362: 14312.
  • 20
    Barb D,Williams CJ,Neuwirth AK,Mantzoros CS. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr 2007; 86: s858s66.
  • 21
    Otake S,Takeda H,Suzuki Y,Fukui T,Watanabe S,Ishihama K,Saito T,Togashi H,Nakamura T,Matsuzawa Y,Kawata S. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 2005; 11: 36426.
  • 22
    Lukanova A,Soderberg S,Kaaks R,Jellum E,Stattin P. Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 4012.
  • 23
    Fukumoto J,Otake T,Tajima O,Tabata S,Abe H,Mizoue T,Ohnaka K,Kono S. Adiponectin and colorectal adenomas: Self Defence Forces Health Study. Cancer Sci 2008; 99: 7816.
  • 24
    Combs TP,Pajvani UB,Berg AH,Lin Y,Jelicks LA,Laplante M,Nawrocki AR,Rajala MW,Parlow AF,Cheeseboro L,Ding YY,Russell RG, et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 2004; 145: 36783.
  • 25
    Bissahoyo A,Pearsall RS,Hanlon K,Amann V,Hicks D,Godfrey VL,Threadgill DW. Azoxymethane is a genetic background-dependent colorectal tumor initiator and promoter in mice: effects of dose, route, and diet. Toxicol Sci 2005; 88: 3405.
  • 26
    Guo JY,Li X,Browning JD,Jr,Rottinghaus GE,Lubahn DB,Constantinou A,Bennink M,MacDonald RS. Dietary soy isoflavones and estrone protect ovariectomized ERalphaKO and wild-type mice from carcinogen-induced colon cancer. J Nutr 2004; 134: 17982.
  • 27
    Takagi T,Nakano Y,Takekoshi S,Inagami T,Tamura M. Hemizygous mice for the angiotensin II type 2 receptor gene have attenuated susceptibility to azoxymethane-induced colon tumorigenesis. Carcinogenesis 2002; 23: 123541.
  • 28
    Ealey KN,Lu S,Lau D,Archer MC. Reduced susceptibility of muscle-specific insulin receptor knockout mice to colon carcinogenesis. Am J Physiol Gastrointest Liver Physiol 2008; 294: G679G86.
  • 29
    Kelesidis I,Kelesidis T,Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer 2006; 94: 12215.
  • 30
    Giovannucci E,Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007; 132: 220825.
  • 31
    Gravaghi C,Bo J,Laperle KM,Quimby F,Kucherlapati R,Edelmann W,Lamprecht SA. Obesity enhances gastrointestinal tumorigenesis in Apc-mutant mice. Int J Obes (Lond) 2008; 32: 17169.
  • 32
    Ealey KN,Xuan W,Lu S,Archer MC. Colon carcinogenesis in liver-specific IGF-I-deficient (LID) mice. Int J Cancer 2008; 122: 4726.
  • 33
    Haluzik M,Yakar S,Gavrilova O,Setser J,Boisclair Y,LeRoith D. Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance. Diabetes 2003; 52: 24839.
  • 34
    Ogunwobi OO,Beales IL. Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul Pept 2006; 134: 10513.
  • 35
    Fenton JI,Birmingham JM,Hursting SD,Hord NG. Adiponectin blocks multiple signaling cascades associated with leptin-induced cell proliferation in Apc Min/+ colon epithelial cells. Int J Cancer 2008; 122: 243745.